For the relative few of us focused on uplistings, a reverse split is typically the first catalyst that attracts attention to the potential uplisting and is considered a very good event.
As for the timing on the uplisting for Biostar, that is solely up to Nasdaq. However, according to the company's chief financial officer, the company already meets all of the corporate governance requirements and has already applied to Nasdaq for an uplisting.
On Tuesday, Biostar's last aftermarket price was $4.35 and the closing bid was $4.30.
At the time of publication, Pearson was long Biostar.